Fax: (713) 563-0566
Original Article
Prevalence of complementary medicine use in a phase 1 clinical trials program†
The MD Anderson Cancer Center Experience
Article first published online: 28 APR 2011
DOI: 10.1002/cncr.26164
Copyright © 2011 American Cancer Society
Additional Information
How to Cite
Naing, A., Stephen, S. K., Frenkel, M., Chandhasin, C., Hong, D. S., Lei, X., Falchook, G., Wheler, J. J., Fu, S. and Kurzrock, R. (2011), Prevalence of complementary medicine use in a phase 1 clinical trials program. Cancer, 117: 5142–5150. doi: 10.1002/cncr.26164
- †
We acknowledge Joann Aaron, Senait Fessahaye, and Jean T. Pham-Roy for manuscript editing and data collection.
Publication History
- Issue published online: 3 NOV 2011
- Article first published online: 28 APR 2011
- Manuscript Accepted: 7 MAR 2011
- Manuscript Revised: 11 FEB 2011
- Manuscript Received: 27 DEC 2010
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
